638 related articles for article (PubMed ID: 19147051)
1. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association.
Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
J Am Coll Cardiol; 2009 Jan; 53(3):298-304. PubMed ID: 19147051
[No Abstract] [Full Text] [Related]
2. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
Circulation; 2009 Jan; 119(2):351-7. PubMed ID: 19095622
[No Abstract] [Full Text] [Related]
3. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.
Lund SS; Vaag AA
Diabetes Care; 2009 Jul; 32(7):e90-1; author reply e92-3. PubMed ID: 19564469
[No Abstract] [Full Text] [Related]
4. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association.
Skyler JS; Bergenstal R; Bonow RO; Buse J; Deedwania P; Gale EA; Howard BV; Kirkman MS; Kosiborod M; Reaven P; Sherwin RS; ; ;
Diabetes Care; 2009 Jan; 32(1):187-92. PubMed ID: 19092168
[No Abstract] [Full Text] [Related]
5. Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
Gilpin VL; ; ;
J Vasc Nurs; 2010 Dec; 28(4):154-5. PubMed ID: 21074118
[No Abstract] [Full Text] [Related]
6. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials.
Mannucci E; Monami M; Lamanna C; Gori F; Marchionni N
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):604-12. PubMed ID: 19427768
[TBL] [Abstract][Full Text] [Related]
7. Implications of intensive glycemic control on cardiovascular disease: early reports from the ACCORD and ADVANCE Trials.
Soo Yeon S; Nesto RW
Rev Cardiovasc Med; 2008; 9(1):1-4. PubMed ID: 18418304
[No Abstract] [Full Text] [Related]
8. Should you put all diabetic patients on statins?
Leiter LA
J Fam Pract; 2007 Apr; 56(4):294-300. PubMed ID: 17403328
[No Abstract] [Full Text] [Related]
9. [ACCORD (Action to Control Cardiovascular Risk in Diabetes trial) becoming "two-tone"].
Seufert J
Dtsch Med Wochenschr; 2008 May; 133(20):1068-70. PubMed ID: 18461525
[No Abstract] [Full Text] [Related]
10. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
Buse JB; Ginsberg HN; Bakris GL; Clark NG; Costa F; Eckel R; Fonseca V; Gerstein HC; Grundy S; Nesto RW; Pignone MP; Plutzky J; Porte D; Redberg R; Stitzel KF; Stone NJ; ;
Diabetes Care; 2007 Jan; 30(1):162-72. PubMed ID: 17192355
[TBL] [Abstract][Full Text] [Related]
11. Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials.
Tkác I
Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S57-62. PubMed ID: 20115934
[TBL] [Abstract][Full Text] [Related]
12. Implications of the diabetes control and complications trial. American Diabetes Association.
J Fla Med Assoc; 1998 Aug; 85(2):22-4. PubMed ID: 9782715
[No Abstract] [Full Text] [Related]
13. Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.
Brunzell JD; Davidson M; Furberg CD; Goldberg RB; Howard BV; Stein JH; Witztum JL; ;
Diabetes Care; 2008 Apr; 31(4):811-22. PubMed ID: 18375431
[No Abstract] [Full Text] [Related]
14. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
[No Abstract] [Full Text] [Related]
15. Controlling blood glucose levels in patients with type 2 diabetes mellitus. An evidence-based policy statement by the American Academy of Family Physicians and American Diabetes Association.
Woolf SH; Davidson MB; Greenfield S; Bell HS; Ganiats TG; Hagen MD; Palda VA; Rizza RA; Spann SJ
J Fam Pract; 2000 May; 49(5):453-60. PubMed ID: 10836779
[TBL] [Abstract][Full Text] [Related]
16. Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves.
Sherman FT
Geriatrics; 2008 Aug; 63(8):8-10. PubMed ID: 18672951
[No Abstract] [Full Text] [Related]
17. Type 2 diabetes mellitus: prevention of macrovascular complications.
Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
[TBL] [Abstract][Full Text] [Related]
18. ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association.
Bairey Merz CN; Alberts MJ; Balady GJ; Ballantyne CM; Berra K; Black HR; Blumenthal RS; Davidson MH; Fazio SB; Ferdinand KC; Fine LJ; Fonseca V; Franklin BA; McBride PE; Mensah GA; Merli GJ; O'Gara PT; Thompson PD; Underberg JA; ; ; ; ; ; ; ; ; ; ;
Circulation; 2009 Sep; 120(13):e100-26. PubMed ID: 19770387
[No Abstract] [Full Text] [Related]
19. Glycemic targets for patients with type 2 diabetes mellitus.
Hamnvik OP; McMahon GT
Mt Sinai J Med; 2009 Jun; 76(3):227-33. PubMed ID: 19421966
[TBL] [Abstract][Full Text] [Related]
20. Fasting and post-prandial glucose and diabetic complication. A meta-analysis.
Monami M; Adalsteinsson JE; Desideri CM; Ragghianti B; Dicembrini I; Mannucci E
Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):591-8. PubMed ID: 23711419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
